SCHEMBL3196452

SCHEMBL3196452

O=C1C(=Cc2ccc(O)c(O)c2)CCC1=Cc1ccc(O)c(O)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.73
GAA P10253 1/20 0.73
SI P14410 1/20 0.73
MGAM2 Q2M2H8 1/20 0.73
CYP2C9 P11712 4/20 0.66
CYP1A2 P05177 2/20 0.66
CYP3A4 P08684 2/20 0.66
MEN1 O00255 2/20 0.66
KMT2A Q03164 2/20 0.66
KDM4E B2RXH2 1/20 0.66
POLB P06746 1/20 0.66
MAPT P10636 1/20 0.66
THRB P10828 1/20 0.66
MAPK1 P28482 1/20 0.66
ATM Q13315 1/20 0.66
EGFR P00533 1/20 0.64
EP300 Q09472 1/20 0.63
MIF P14174 2/20 0.61
STK17B O94768 1/20 0.58
JUN P05412 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3259939 0.93 MGAM (0.85) MGAMGAASIMGAM2CYP2C9
SCHEMBL14259649 0.93 MGAM (0.85) MGAMGAASIMGAM2CYP2C9
SCHEMBL7624219 0.85 MIF (0.70) MGAMGAASIMGAM2POLB
SCHEMBL3260660 0.85 MGAM (0.60) MGAMGAASIMGAM2CYP2C9
SCHEMBL3260661 0.85 MGAM (0.60) MGAMGAASIMGAM2CYP2C9
SCHEMBL31432866 0.85 MGAM (0.60) MGAMGAASIMGAM2CYP2C9
SCHEMBL17077360 0.85 EGFR (0.90) CYP2C9CYP1A2CYP3A4MEN1KMT2A
SCHEMBL17077357 0.85 EGFR (0.90) CYP2C9CYP1A2CYP3A4MEN1KMT2A
SCHEMBL14259657 0.84 MGAM (0.72) MGAMGAASIMGAM2CYP2C9
SCHEMBL14259648 0.84 MGAM (0.72) MGAMGAASIMGAM2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859625-B2 Methods to prepare penta-1,4-dien-3-ones and substituted cyclohexanones and derivatives with antitumoral and antiparasitic properties, the compounds and their uses UNIVERSIDADE BANDEIRANTE DE SAO PAULO-ACADEMIA, PAULISTA ANCHIETA S/C LTDA (BR) 2014-10-14 US disclosed
EP-2054365-B1 METHODS TO PREPARE PENTA-1,4-DIEN-3-ONES AND SUBSTITUTED CYCLOHEXANONES AND DERIVATIVES WITH ANTITUMORAL AND ANTIPARASITIC PROPERTIES, THE COMPOUNDS AND THEIR USES UNIBAN UNIVERSIDADE BANDEIRANTE DE S O PAULO (BR) 2014-09-24 EP disclosed
US-20100029763-A1 METHODS TO PREPARE PENTA-1,4-DIEN-3-ONES AND SUBSTITUTED CYCLOHEXANONES AND DERIVATIVES WITH ANTITUMORAL AND ANTIPARASITIC PROPERTIES, THE COMPOUNDS AND THEIR USES UNIVERSIDADE BANDEIRANTE DE SAO PAULO-ACADEMIA, PAULISTA ANCHIETA S/C LTDA (BR) 2010-02-04 US disclosed
EP-2054365-A2 METHODS TO PREPARE PENTA-1,4-DIEN-3-ONES AND SUBSTITUTED CYCLOHEXANONES AND DERIVATIVES WITH ANTITUMORAL AND ANTIPARASITIC PROPERTIES, THE COMPOUNDS AND THEIR USES Uniban - Universidade Bandeirante De São Paulo (BR) 2009-05-06 EP disclosed
WO-2008003155-A2 METHODS TO PREPARE PENTA-1,4-DIEN-3-ONES AND SUBSTITUTED CYCLOHEXANONES AND DERIVATIVES WITH ANTITUMORAL AND ANTIPARASITIC PROPERTIES, THE COMPOUNDS AND THEIR USES UNIBAN - UNIVERSIDADE BANDEIRANTE DE SÃO PAULO - ACADEMIA PAULISTA ANCHIETA S/C LTDA (BR) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029763-A1 METHODS TO PREPARE PENTA-1,4-DIEN-3-ONES AND SUBSTITUTED CYCLOHEXANONES AND DERIVATIVES WITH ANTITUMORAL AND ANTIPARASITIC PROPERTIES, THE COMPOUNDS AND THEIR USES CASP3, CYP8B1, DERA MGAM 2219/4885GAA 364/4885SI 483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.